Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$649M |
| 2 |
Weyerhaeuser
WY
|
+$353M |
| 3 |
IQVIA
IQV
|
+$135M |
| 4 |
Halliburton
HAL
|
+$135M |
| 5 |
Dover
DOV
|
+$119M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.73B |
| 2 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$709M |
| 3 |
Health Care Select Sector SPDR Fund
XLV
|
+$468M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$261M |
Sector Composition
| 1 | Technology | 14.2% |
| 2 | Healthcare | 11.67% |
| 3 | Financials | 10.34% |
| 4 | Consumer Discretionary | 9.34% |
| 5 | Communication Services | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KND
2551
DELISTED
Kindred Healthcare
KND
| $122K | ﹤0.01% |
17,988
-20,873
| -54% | -$142K |
|
|
ACET
2552
DELISTED
Aceto Corp
ACET
| $121K | ﹤0.01% |
10,752
+4,960
| +86% | +$55.8K |
|
2553
Aurinia Pharmaceuticals
AUPH
$1.68B
| $120K | ﹤0.01% |
19,100
+16,300
| +582% | +$102K |
|
2554
Fonar
FONR
$98.8M
| $120K | ﹤0.01% |
3,941
+136
| +4% | +$4.14K |
|
2555
Knowles
KN
$1.9B
| $120K | ﹤0.01% |
7,912
-2,286
| -22% | -$34.7K |
|
2556
Invesco Semiconductors ETF
PSI
$907M
| $120K | ﹤0.01% |
7,260
| – | – |
|
|
ACGN
2557
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $120K | ﹤0.01% |
396
+395
| +39,500% | +$120K |
|
2558
Mueller Industries
MLI
$11B
| $119K | ﹤0.01% |
6,832
-6,858
| -50% | -$119K |
|
|
CSFL
2559
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $119K | ﹤0.01% |
4,419
+4,381
| +11,529% | +$118K |
|
|
NCI
2560
DELISTED
Navigant Consulting, Inc.
NCI
| $119K | ﹤0.01% |
7,026
-38,103
| -84% | -$645K |
|
2561
Sterling Infrastructure
STRL
$9.54B
| $118K | ﹤0.01% |
7,744
-631
| -8% | -$9.62K |
|
2562
Turning Point Brands
TPB
$1.84B
| $118K | ﹤0.01% |
6,901
-985
| -12% | -$16.8K |
|
2563
Varex Imaging
VREX
$469M
| $118K | ﹤0.01% |
3,472
-10,212
| -75% | -$347K |
|
|
GTHX
2564
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $118K | ﹤0.01% |
4,719
+3,919
| +490% | +$98K |
|
|
CNCE
2565
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $118K | ﹤0.01% |
7,982
+7,673
| +2,483% | +$113K |
|
|
IBLN
2566
DELISTED
Direxion iBillionaire Index ETF
IBLN
| $118K | ﹤0.01% |
3,850
| – | – |
|
2567
iShares MSCI Europe Financials ETF
EUFN
$4.47B
| $117K | ﹤0.01% |
5,000
-2,200
| -31% | -$51.5K |
|
2568
John B. Sanfilippo & Son
JBSS
$737M
| $117K | ﹤0.01% |
1,743
-788
| -31% | -$52.9K |
|
2569
SFL Corp
SFL
$1.06B
| $117K | ﹤0.01% |
8,136
+8,059
| +10,466% | +$116K |
|
2570
Catalyst Pharmaceutical
CPRX
$2.44B
| $116K | ﹤0.01% |
46,080
+30,001
| +187% | +$75.5K |
|
2571
MannKind Corp
MNKD
$1.71B
| $116K | ﹤0.01% |
53,567
-58,856
| -52% | -$127K |
|
2572
Materion
MTRN
$2.31B
| $116K | ﹤0.01% |
2,697
-2,772
| -51% | -$119K |
|
|
ATNX
2573
DELISTED
Athenex, Inc. Common Stock
ATNX
| $116K | ﹤0.01% |
+330
| New | +$116K |
|
2574
Babcock & Wilcox
BW
$281M
| $115K | ﹤0.01% |
3,415
+2,409
| +239% | +$81.1K |
|
2575
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $115K | ﹤0.01% |
8,639
-13,008
| -60% | -$173K |
|